Professor | Xiao Gengfu | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Xiao Gengfu

Contact Information

xiaogf@wh.iov.cn

Language ability

Chinese, English

Province

Hubei

University/Lab Affiliation and Title	University of Chinese Academy of Sciences
Faculty	Life Sciences
Academic Background & Achievements	1995-09 PhD in Science: Wuhan University 1989-09 Master's in Medicine: Tongji Medical University 1984-09 Bachelor's in Medicine: Tongji Medical University
Work Experience	1995-09~Present - Wuhan University - PhD in Science 1989-09~Present - Tongji Medical University - Master's in Medicine 1984-09~Present - Tongji Medical University - Bachelor's in Medicine 2020-12-25~Present - Hubei Jiangxia Laboratory - Director 2018-05-08~Present - National Key R&D Program 'Protein Machine' - Member
Awards	State Council Special Government Allowance (2018): First Prize, National Level

University/Lab Affiliation and Title

University of Chinese Academy of Sciences

Faculty

Life Sciences

Academic Background & Achievements

Work Experience

Awards

Areas of Focus	Biochemistry of Viruses Virology
Publications	A nanoluciferase SFTSV for rapid screening antivirals and real-time visualization of virus infection in mice, 9th Author, 2024 Synthesis of maleimide-braced peptide macrocycles and their potential anti-SARS-CoV-2 mechanisms, 11th Author, 2023 Impact of SARS-CoV-2 envelope protein mutations on the pathogenicity of Omicron XBB, 5th Author, 2023 Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2, 10th Author, 2023 High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors, 11th Author, 2023 Regulation of the WNT-CTNNB1 signaling pathway by severe fever with thrombocytopenia syndrome virus in a cap-snatching manner, 11th Author, 2023 CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity, 24th Author, 2022 Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library, 11th Author, 2022 Target-Based Virtual Screening and LC/MS-Guided Isolation Procedure for Identifying Phloroglucinol-Terpenoid Inhibitors of SARS-CoV-2, 9th Author, 2022 Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19, 10th Author, 2022

Areas of Focus

Biochemistry of Viruses
Virology

Publications

A nanoluciferase SFTSV for rapid screening antivirals and real-time visualization of virus infection in mice, 9th Author, 2024
Synthesis of maleimide-braced peptide macrocycles and their potential anti-SARS-CoV-2 mechanisms, 11th Author, 2023
Impact of SARS-CoV-2 envelope protein mutations on the pathogenicity of Omicron XBB, 5th Author, 2023
Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2, 10th Author, 2023
High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors, 11th Author, 2023
Regulation of the WNT-CTNNB1 signaling pathway by severe fever with thrombocytopenia syndrome virus in a cap-snatching manner, 11th Author, 2023
CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity, 24th Author, 2022
Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library, 11th Author, 2022
Target-Based Virtual Screening and LC/MS-Guided Isolation Procedure for Identifying Phloroglucinol-Terpenoid Inhibitors of SARS-CoV-2, 9th Author, 2022
Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19, 10th Author, 2022

Virus Biochemistry Molecular Biology Pathogenesis Infection Antiviral Vaccine Immunology Genetics Proteomics

Xiaobo Zhang - Zhejiang University

Daming Zhou - Zhejiang University

Li Yang - University of Chinese Academy of Sciences

View All

Personal Information